Companies / Viking Therapeutics Inc
Viking Therapeutics Inc
Nasdaq: VKTXCIK 1607678SAN DIEGO, CA
Financials · FY2025
Ownership
116.7M shares outstanding · as of Jul 15, 2026
Ownership
| Insiders | 2.50% | 2,921,283 |
| Institutions | 65.47% | 76,372,662 |
| Public float | 32.03% | 37,358,992 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 10
View all →| Insider | % of shares | Shares |
|---|---|---|
Lian BrianCEOPresident & CEO · Director | 2.14% | 2,499,291 |
Mancini MariannaFormerChief Operating Officer | 0.35% | 409,190 |
Zante GregChief Financial Officer | 0.16% | 189,891 |
Foehr Matthew WDirector | 0.12% | 135,186 |
Macartney LawsonDirector | 0.04% | 51,115 |
Rowland Charles A JrDirector | 0.03% | 33,150 |
Singleton J MatthewDirector | 0.01% | 12,650 |
Aubuchon Neil WilliamFormerChief Commercial Officer | <0.01% | 4,475 |
Rouan Sarah KathrynFormerDirector | <0.01% | 4,390 |
Kelly-Gemmell Dorothy ElizabethFormerDirector | — | — |
Institutional holders 438
View all →| Holder | Value | % of shares |
|---|---|---|
| $351.25M | 8.56% | |
| $241.46M | 5.31% | |
| $230.70M | 5.62% | |
| $218.71M | 4.81% | |
| $144.22M | 3.80% | |
| $108.22M | 2.64% | |
| $74.91M | 1.83% | |
| $67.77M | 1.78% | |
| $60.95M | 1.49% | |
| $54.56M | 1.44% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Two Sigma Investments, LP 13F manager | Add | — | $64.96M | +2.0M +81.96% | 4,432,142 3.80% of shares | high |
| Q2 2026 as of | State Street Corporation 13F manager | Add | — | $45.29M | +1.2M +26.12% | 5,606,394 4.81% of shares | medium |
| Q4 2025 as of | Norges Bank 13F manager | Exit | — | $-37.32M | -1.5M -100.00% | — | medium |
| Q1 2024 as of | Barclays PLC 13F manager | Trim | — | $-32.07M | -391K -72.47% | 148,603 0.13% of shares | medium |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Trim | — | $-16.47M | -422K -6.39% | 6,189,649 5.31% of shares | medium |
| Q1 2026 as of | BNP Paribas Financial Markets 13F manager | Trim | — | $-14.71M | -452K -45.55% | 540,499 0.46% of shares | medium |
| Q1 2025 as of | Barclays PLC 13F manager | Add | — | $8.53M | +353K +381.54% | 445,695 0.38% of shares | medium |
| Q4 2025 as of | Bank of America Corp /De 13F manager | Trim | — | $-8.15M | -232K -40.05% | 346,647 0.30% of shares | medium |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| VKTX | — | 92686J106 |